Abstract
Hepatocellular carcinoma (HCC) with more than 700,000 deaths every year is the most prevalent type of liver cancer and a global concern. It is the fifth most common cancer worldwide and has a poor general prognosis. Chronic hepatitis B virus (HBV) infection is a major cause of HCC. The HBV-infected individual has 100 times higher risk of developing HCC. The x protein of HBV (HBx) has been shown to involve in the development of HCC. In this study, the association between HBV replication and the host cell metabolism is investigated. HepG2 cells are transfected with different genotypes of HBx and total proteins are extracted and analyzed using LC-MS/MS. Our proteomics results indicates that a number of glycolytic enzymes including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase (PK), Phosphoglyceratekinase (PGK) and Lactate dehydrogenase (LDH) are significantly up-regulated in HepG2 cells transfected by HBx comparing with control group. These findings suggest that HBV replication could alter host cell metabolism by increasing the rate of glycolysis to provide important metabolic requirements for nucleotides, amino acids and lipids synthesis. Hence, our proteomics approach may provide candidate biomarkers to improve the diagnosis of HBVrelated HCC patients.
Keywords: Biomarker, HBV, HBx, HCC, LC-MS/MS, metabolic enzymes, proteomics.
Current Proteomics
Title:Role of HBV Replication in Host Cell Metabolism: A Proteomics Analysis
Volume: 10 Issue: 1
Author(s): Laleh Sadrolodabaee, Tiong Keng Low, Huixing Feng and Wei Ning Chen
Affiliation:
Keywords: Biomarker, HBV, HBx, HCC, LC-MS/MS, metabolic enzymes, proteomics.
Abstract: Hepatocellular carcinoma (HCC) with more than 700,000 deaths every year is the most prevalent type of liver cancer and a global concern. It is the fifth most common cancer worldwide and has a poor general prognosis. Chronic hepatitis B virus (HBV) infection is a major cause of HCC. The HBV-infected individual has 100 times higher risk of developing HCC. The x protein of HBV (HBx) has been shown to involve in the development of HCC. In this study, the association between HBV replication and the host cell metabolism is investigated. HepG2 cells are transfected with different genotypes of HBx and total proteins are extracted and analyzed using LC-MS/MS. Our proteomics results indicates that a number of glycolytic enzymes including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase (PK), Phosphoglyceratekinase (PGK) and Lactate dehydrogenase (LDH) are significantly up-regulated in HepG2 cells transfected by HBx comparing with control group. These findings suggest that HBV replication could alter host cell metabolism by increasing the rate of glycolysis to provide important metabolic requirements for nucleotides, amino acids and lipids synthesis. Hence, our proteomics approach may provide candidate biomarkers to improve the diagnosis of HBVrelated HCC patients.
Export Options
About this article
Cite this article as:
Sadrolodabaee Laleh, Low Keng Tiong, Feng Huixing and Chen Ning Wei, Role of HBV Replication in Host Cell Metabolism: A Proteomics Analysis, Current Proteomics 2013; 10 (1) . https://dx.doi.org/10.2174/15701646112099990008
DOI https://dx.doi.org/10.2174/15701646112099990008 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Current Gene Therapy MEET THE GUEST EDITOR [Hot Topic: Modern Omics-Based Platform for High Throughput Screening for Novel Drug Targets (Part 2) (Guest Editor: Canhua Huang)]
Combinatorial Chemistry & High Throughput Screening Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity
Current Medicinal Chemistry A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro
Anti-Cancer Agents in Medicinal Chemistry Haploidentical Stem Cell Transplantation in Childhood
Current Cancer Therapy Reviews Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets ABC Transporters as Potential Targets for Modulation of Drug Resistance
Mini-Reviews in Medicinal Chemistry Exploring the Chemical Space of P-Glycoprotein Interacting Compounds
Mini-Reviews in Medicinal Chemistry The Influence of Diabetes in the Pathogenesis and the Clinical Course of Hepatocellular Carcinoma: Recent Findings and New Perspectives
Current Diabetes Reviews New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia
Mini-Reviews in Medicinal Chemistry Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
Current Drug Targets Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy
Current Cancer Drug Targets Characterization of the Lymphotropic Amplicons-6 and Tamplicon-7 Vectors Derived from HHV-6 and HHV-7
Current Gene Therapy Pyrrolizidine Alkaloids and their Biological Properties from Indian Heliotropium Species
Current Bioactive Compounds